glp-1 colorectal cancer death risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Ozempic, Wegovy might lower colon GLP-1 drugs linked to dramatically

I get emails checking to see how I am doing on my journey

GLP-1(2836) contributes to the cardiovascular biology of GLP-1

Furthermore, the EMA has withdrawn the weight loss medication rimonabant, a selective cannabinoid type 1 receptor antagonist, due to its reported links to increased risks of depression and suicide [70]

Metastasis is strongly reduced by the matrix metalloproteinase inhibitor galardin in the MMTV-PymT transgenic breast cancer model

Other GLP1 receptor agonists, such as Trulicity (dulaglutide), Wegovy (also semaglutide but at a higher dose for weight loss), and Victoza (liraglutide), offer similar mechanisms but vary in dosing frequency, cost, and clinical indications

doi: 10.1513/pats.200708-137mg, 10